Monocarboxylate transporters: Past, present, and future

Histology and Histopathology

Volumn 24, Issue 2, 2009, Pages 243-264

  Merezhinskaya, Natalya ^a   Fishbein, William N ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Immunocytochemistry; Immunohistochemistry; Intercellular lactate shuttle; Lactate transporters; Monocarboxylate transporters; Subcellular organelles

Indexed keywords

AROMATIC AMINO ACID; CHAPERONIN; LACTIC ACID; MITOCHONDRIAL PROTEIN; MONOCARBOXYLATE TRANSPORTER; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 2; MONOCARBOXYLATE TRANSPORTER 3; MONOCARBOXYLATE TRANSPORTER 4; PYRUVIC ACID; THYROID HORMONE; CARRIER PROTEIN; LACTIC ACID DERIVATIVE;

ACIDOSIS; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; BLOOD PH; CARBOXY TERMINAL SEQUENCE; CELL HYPOXIA; CELL INTERACTION; CELL KINETICS; CROSS REACTION; CYTOSOL; DISEASE COURSE; GENE IDENTIFICATION; GENE MUTATION; GENETIC CONSERVATION; GENETIC DISORDER; GENETIC VARIABILITY; HEART MUSCLE ISCHEMIA; HETEROZYGOTE; HUMAN; IMMUNE RESPONSE; LEUKOCYTE; METABOLITE; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; PSYCHOMOTOR RETARDATION; REGULATORY MECHANISM; REVIEW; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; X CHROMOSOME LINKED DISORDER; ANIMAL; BIOLOGICAL MODEL; CELL FRACTIONATION; CELL MEMBRANE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; METABOLISM; METHODOLOGY; MUTATION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL MEMBRANE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LACTATES; MEMBRANE TRANSPORT PROTEINS; MODELS, BIOLOGICAL; MONOCARBOXYLIC ACID TRANSPORTERS; MUTATION; SUBCELLULAR FRACTIONS;

EID: 59149090614     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Allan W., Herndon C.W. and Dudley F.C. (1944). Some examples of the inheritance of mental deficiency: apparently sex-linked idiocy and microcephaly. Am. J. Mental Defic. 48, 325-334.
2. Allen D. and Westerblad H. (2004). Lactic acid - the latest performance enhancing drug. Science 305, 1112-1113.
3. Beale E.G., Hammer R.E., Antoine B. and Forest C. (2002). Glyceroneogenesis comes of age. FASEB J. 16, 1695-1696.
4. Benton C.R., Campbell S.E., Tonouchi M., Hatta H. and Bonen A. (2004). Monocarboxylate transporters in subsarcolemmal and intermyofibrillar mitochondria. Biochem. Biophys. Res. Commun. 323, 249-253.
5. Bolli R., Nalecz K.A. and Azzi A. (1989). Monocarboxylate and α-ketoglutarate carriers from bovine heart mitochondria. Purification by affinity chromatography on immobilized 2-cyano-4-hydroxy-cinnamate. J. Biol. Chem. 264, 18024-18030.
6. Bonen A., Miskovic D., Tonouchi M., Lemieux K., Wilson M.C., Marette A. and Halestrap A.P. (2000). Abundance and subcellular distribution of MCT1 and MCT4 in heart and fast-twitch skeletal muscles. Am. J. Physiol. Endocrinol. Metab. 278, E1067-E1077.
7. Bonen A., Heynen M. and Hatta H. (2006). Distribution of monocarboxylate transporters MCT1-MCT8 in rat tissues and human skeletal muscle. Appl. Physiol. Nutr. Metab. 31, 31-39.
8. Brandt R.B., Laux J.E., Spainhour S.E. and Kline E.S. (1987). Lactate dehydrogenase in rat mitochondria. Arch. Biochem. Biophys. 259, 412-422.
9. Brauchi S., Rauch M.C., Alfaro I.E., Cea C., Concha I.I., Benos D.J. and Reyes J.G. (2005). Kinetics, molecular basis, and differentiation of L-lactate transport in spermatogenic cells. Am. J. Physiol. Cell Physiol. 288, C523-C534.
10. Bröer S., Schneider H.-P., Bröer A., Rahman B., Hamprecht B. and Deitmer J.W. (1998). Characterization of the monocarboxylate transporter 1 expressed in Xenopus laevis oocytes by changes in cytosolic pH. Biochem. J. 333, 167-174.
11. Brooks G.A., Brown M., Bitz C.E., Sicurello J.P. and Dubouchaud H. (1999a). Cardiac and skeletal muscle mitochondria have a monocarboxylate transporter MCT1. J. Appl. Physiol. 87, 1713-1718.
12. Brooks G.A., Dubouchaud H., Brown M., Sicurello J.P. and Butz C.E. (1999b). Role of mitochondrial lactic dehydrogenase and lactate oxidation in the "intra-cellular lactate shuttle". Proc. Natl. Acad. Sci. USA 96, 1129-1134.
13. Bueno V., Binet I., Steger U., Bundick R., Ferguson D., Murray C., Donald D. and Wood K. (2007). The specific monocarboxylate transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival in mice. Transplantation 84, 1204-1207.
14. Butz C.E., McClelland G. and Brooks G.A. (2004). MCT1 confirmed in rat striated muscle mitochondria. J. Appl. Physiol. 97, 1059-1066.
15. Carpenter L., Poole R.C. and Halestrap A.P. (1996). Cloning and sequencing of the monocarboxylate transporter from mouse Ehrlich Lettre tumour cell confirms its identity as MCT1 and demonstrates that glycosylation is not required for MCT1 function. Biochim. Biophys. Acta 1279, 157-163.
16. Chance B. and Williams G.R. (1955). Respiratory enzymes in oxidative phosphorylation. III. The steady state. J. Biol. Chem. 217, 409-427.
17. Chiry O., Pellerin L., Monnet-Tschudi F., Fishbein W.N., Merezhinskaya N., Magistretti P.J. and Clarke S. (2006). Expression of the monocarboxylate transporter MCT1 in the adult human brain cortex. Brain Res. 1070, 65-70.
18. Cramer T., Yamanishi Y., Clausen B.E., Förster I., Pawlinski R., Mackman N., Haase V.H., Jaenisch R., Corr M., Nizet V., Firestein G.S., Gerber H.-P. and Johnson R.S. (2003). HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112, 645-657.
19. Cuff M.A., Lambert D.W. and Shirazi-Beechey S.P. (2002). Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1. J. Physiol. 539, 361-371.
20. Cuff M.A. and Shirazi-Beechey S.P. (2002). The human monocarboxylate transporter, MCT1: genomic organization and promoter analysis. Biochem. Biophys. Res. Commun. 292, 1048-1056.
21. Deuticke B., Rickert I and Beyer E. (1978). Stereoselective, SH-dependent transfer of lactate in mammalian erythrocytes. Biochim. Biophys. Acta 509, 21-32.
22. Dimitrescu A.M., Liao X.-H., Best T.B., Brockmann K. and Refetoff S. (2004). A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am. J. Hum. Gen. 74, 168-175.
23. Dimmer K.-S., Friedrich B., Lang F., Deitmer J.W. and Bröer S. (2000). The low- affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem. J. 350, 219-227.
24. Dubinsky W.P. and Racker E. (1978). The mechanism of lactate transport in human erythrocytes. J. Membr. Biol. 44, 25-36.
25. Dzeja P.P., Zeleznikar R.J. and Goldberg N.D. (1996). Suppression of creatine kinase-catalyzed phosphotransfer results in increased phosphoryl transfer by adenylate kinase in intact skeletal muscle. J. Biol. Chem. 271, 12847-12851.
26. Dzeja P.P., Bortolon R., Perez-Terzic C., Holmuhamedov E.L. and Terzic A. (2002). Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer. Proc. Natl. Acad. Sci. USA 99, 10156-10161.
27. Ekberg H., Qi Z., Pahlman C., Veress B., Bundick R.V., Craggs R.I., Holness E., Edwards S., Murray C.M., Ferguson D., Kerry P.J., Wilson E. and Donald D.K. (2007). The specific monocarboxylate transporter-1 (MCT1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat. Transplantation 84, 1191-1199.
28. Fishbein W.N. (1986) Lactate transporter defect: a new disease of muscle. Science 234, 1254-1256.
29. Fishbein W.N., Foellmer J.W., Davis J.I., Fishbein T.M. and Armbrustmacher P. (1988). Clinical assay of the human erythrocyte lactate transporter. I. Principles, procedure, and validation. Biochem. Med. Metab. Biol. 39, 338-350.
30. Fishbein W.N., Merezhinskaya N. and Foellmer J. (2002). Relative distribution of three major lactate transporters in frozen human tissues and their localization in unfixed skeletal muscle. Muscle Nerve 26, 101-112.
31. Frey T.G., Renken C.W. and Perkins G.A. (2002). Insight into mitochondrial structure and function from electron tomography. Biochim. Biophys. Acta 1555, 196-203.
32. Frey T.G., Perkins G.A. and Ellisman M.H. (2006). Electron tomography of membrane-bound cellular organelles. Annu. Rev. Biophys. Biomol. Struct. 35, 199-224.
33. Friesema E.C.H., Gangluy S., Abdalla A., Manning Fox J.E., Halestrap A.P. and Visser T.J. (2003). Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J. Biol. Chem. 278, 40128-40135.
34. Friesema E.C.H., Grueters A., Bieberman H., Krude H., von Moers A., Reeser M., Barrett T.G., Mancilla E.E., Svensson J., Kester G.G.J.M., Balkassmi S., Uitterlinden A.G., Koehrle J., Rodien P., Halestrap A.P. and Vissar T. (2004). Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364, 1435-1437.
35. Friesema E.C.H., Jansen J., Jachtenberg J-W., Visser W.E., Kester M.H.A. and Visser T.J (2008). Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10 (MCT10). Mol. Endocrinol. 22, 1357-1369.
36. Galic S., Schneider H-P., Broer A., Deitmer J.W. and Broer S. (2003). The loop between helix 4 and helix 5 in the monocarboxylate transporter MCT1 is important for substrate selection and protein stability. Biochem. J. 376, 413-422.
37. Garcia C.K., Brown M.S., Pathak R.K. and Goldstein J.L. (1995). cDNA cloning of MCT2, a second monocarboxylate transporter expressed in different cells than MCT1. J. Biol. Chem. 270, 1843-1849.
38. Giardina B., Ascenzi P., Clementi M.E., De Sanctis G., Rizzi M. and Coletta M. (1996). Functional modulation by lactate of myoglobin. J. Biol. Chem. 271, 16999-17001.
39. Gladden L.B. (2004). Lactate metabolism: a new paradigm for the third millennium. J. Physiol. 558, 5-30.
40. Halestrap A. (1975). The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors. Biochem. J. 148, 85-96.
41. Halestrap A.P. (1976). Transport of pyruvate and lactate into human erythrocytes. Evidence for the involvement of the chloride carrier and a chloride-independent carrier. Biochem. J. 156, 193-207.
42. Halestrap A.P. and Denton R.M. (1974). Specific inhibition of pyruvate transport in rat liver mitochondria and human erythrocytes by α-cyano-4-hydroxycinnamate. Biochem. J. 138, 313-316.
43. Halestrap A.P. and Denton R.M. (1975). The specificity and metabolic implications of the inhibition of pyruvate transport in isolated mitochondria and intact tissue preparations by alpha-Cyano-4-hydroxycinnamate and related compounds. Biochem. J. 148, 97-106.
44. Halestrap A.P. and Price N.T. (1999). The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem. J. 343, 281-299.
45. Halestrap A.P. and Meredith D. (2004). The SLC16 gene family - from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch. 447, 619-628.
46. Hashimoto T., Masuda S., Taguchi S. and Brooks G.A. (2005). Immunohistochemical analysis of MCT1, MCT2, and MCT4 expression in rat plantaris muscle. J. Physiol. 567, 121-129.
47. Hashimoto T., Hussien R. and Brooks G.A. (2006). Colocalization of MCT1, CD147, and LDH in mitochondrial inner membrane of L6 muscle cells: evidence of a mitochondrial lactate oxidation complex. Am. J. Physiol. Endocrinol. Metab. 290, E1237-E1244.
48. Henderson P.J.F. (1993). The 12-transmembrane helix transporters. Curr. Op. Cell Biol. 5, 708-721.
49. Hildyard J.C. and Halestrap A.P. (2003). Identification of the mitochondrial pyruvate carrier in Saccharomyces cerevisiae. Biochem. J. 374, 607-611.
50. Hildyard J.C., Ammälä C., Dukes I.D., Thomson S.A. and Halestrap A.P. (2005). Identification and characterization of a new class of highly specific and potent inhibitors of the mitochondrial pyruvate carrier. Biochim. Biophys. Acta 1707, 221-230.
51. Iizuka K., Morita N., Nagai T., Hanada A., Okita K., Yonezawa K., Murakami T., Kitabake A. and Kawaguchi H. (2003). A 44-kDa of protein identical to the N-terminal amino acid sequence of MCT1 in human circulation. Mol. Cell. Biochem. 248, 217-223.
52. Jobsis F.F. and Duffield J.C. (1967). Oxidative and glycolytic recovery metabolism in muscle. J. Gen. Physiol. 50, 1009-1047.
53. Johannsson E., Nagelhus E.A., McCullagh K.J.A., Sejersted O.M., Blackstad T.W., Bonen A. and Ottersen O.P. (1997). Cellular and subcellular expression of the monocarboxylate transporter MCT1 in rat heart. Circ. Res. 80, 400-407.
54. Kasischke K.A., Vishwasrao H.D., Fisher P.J., Zipfel W.R. and Webb W.W. (2004). Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 305, 99-103.
55. + /monocarboxylate transporters. J. Biol. Chem. 276, 17221-17228.
56. Kim Garcia C., Goldstein J.L., Pathak R.K., Anderson R.G.W. and Brown M. (1994a). Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle. Cell 76, 865-873.
57. Kim Garcia C., Li X., Luna J. and Francke U. (1994b). cDNA cloning of the human monocarboxylate trasporter 1 and chromosomal localization of the SLC16A1 locus to 1p13.2-p12. Genomics 23, 500-503.
58. Kirk P., Wilson M.C., Heddle C., Brown M.H., Barclay A.N. and Halestrap A.P. (2000). CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J. 19, 3896-3904.
59. Kline E.S., Brandt R.B., Laux J.E., Spainhour S.E., Higgins E.S., Rogers K.S., Tinsley S.B. and Waters M.G. (1986). Localization of L-lactate dehydrogenase in mitochondria. Arch. Biochem. Biophys. 246, 673-680.
60. Kolarov J. (2002). ADP/ATP translocase. In: Wiley encyclopedia of molecular medicine. John Wiley and sons. NY. pp 94-97.
61. ATP channels induces profound neonatal diabetes. Cell 100, 645-654.
62. Krebs H.A. (1967). Mitochondrial generation of reducing power. In: Biochemistry of mitochondria. Slater E.C., Kaniuga Z. and Wojtczak L. (eds). Academic Press. NY. pp 105-113.
63. Kristensen M., Albertsen J., Rentsch M. and Juel C. (2005) Lactate and force production in skeletal muscle. J. Physiol. 562, 521-526.
64. Lafreniere R.G., Carrel L. and Willard H.F. (1994). A novel transmembrane transporter encoded by the XPCT gene in Xq13.2. Hum. Mol. Genet. 3, 1133-1139.
65. Laughlin M.R., Taylor J., Chesnick A.S., DeGroot M. and Balaban R.S. (1993). Pyruvate and lactate metabolism in the in vivo dog heart. Am. J. Physiol. Heart Circ. Physiol. 264, 2068-2079.
66. Manning Fox J.E., Meredith D. and Halestrap A.P. (2000). Characterization of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J. Physiol. 529, 285-293.
67. McClelland G.B. and Brooks G.A. (2002). Changes in MCT1, MCT4, and LDH expression are tissue specific in rats after long-term hypobaric hypoxia. J. Applied Physiol. 92, 1573-1584.
68. McClelland G.B., Khanna S., González G.F., Butz C.E. and Brooks G.A. (2003). Peroxisomal membrane monocarboxylate transporters: evidence for a redox shuttle system?. Biochem. Biophys. Res. Commun. 304, 130-135.
69. Merezhinskaya N., Fishbein W.N., Davis J.I. and Foellmer J.W. (2000). Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport. Muscle Nerve 23, 90-97.
70. Merezhinskaya N., Ogunwuyi S.A., Mullick F.G. and Fishbein W.N. (2004). Presence and localization of three lactic acid transporters (MCT1, -2, and -4) in separated human granulocytes, lymphocytes, and monocytes. J. Histochem. Cytochem. 52, 1483-1493.
71. Merezhinskaya N., Ogunwuyi S.A. and Fishbein W.N. (2006). Expression of monocarboxylate transporter 4 in human platelets, leukocytes, and tissues assessed by antibodies raised against terminal versus pre-terminal peptides. Mol. Gen. Metabolism 87, 152-161.
72. Murakami Y., Kohyama N., Kobayashi Y., Ohbayashi M., Ohtani H., Sawada Y. and Yamamoto T. (2005). Functional characterization of human monocarboxylate transporter 6 (SLC 16A5). Drug Met. Disposition 33, 1845-1851.
73. Murray C.M., Hutchinson R., Bantick J.R., Belfield G.P., Benjamin A.D., Brazma D., Bundick R.V., Cook I.D., Craggs R.I., Edwards S., Evans L.R., Harrison R., Holness E., Jackson A.P., Jackson C.G., Kingston L.P., Perry M.W.D., Ross A.R.J., Rugman P.A., Sidhu S.S., Sullivan M., Taylor-Fishwick D.A., Walker P.C., Whitehead Y.M., Wilkinson D.J., Wright A. and Donald D.K. (2005). Monocarboxylate transporter MCT1 is a target for immunosuppression. Nature Chem. Biol. 1, 371-376.
74. Nakai M., Chen L. and Nowak R.A. (2006). Tissue distribution of basigin and monocarboxylate transporter 1 in the adult male mouse: a study using the wild-type and basigin gene knockout mice. Anat. Rec. Part A, 288A, 527-535.
75. Nielsen O.B., de Paoli F. and Overgaard K. (2001). Protective effects of lactic acid on force production in rat skeletal muscle. J. Physiol. 536, 161-166.
76. Otonkoski T., Jiao H., Kaminen-Ahola N., Tapia-Paez I., Ullah M.S., Parton L.E., Schuit F., Quintens R., Sipila I., Mayatepek E., Meissner T., Halestrap A.P., Rutter G.A. and Kere J. (2008). Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic cells. Am. J. Human. Gen. 81, 467- 474.
77. Palmieri F. (2004). The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch. 447, 689-709.
78. Papadimitriou A., Dumitrescu A.M., Papavasiliou A., Fretzayas A., Nicolaidou P. and Refetoff S. (2008). A novel monocarboxylate transporter 8 gene mutation as a cause of severe neonatal hypotonia and developmental delay. Pediatrics 121, e199-202.
79. Parton L.E., Ye C.P., Coppari R., Enriori P.J., Choi B., Zhang C.-Y., Xi C., Vianna C.R., Balthasar N., Lee C.E., Elmquist J.K., Cowley M.A. and Lowell B.B. (2007). Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449, 228-232.
80. Pedersen T.H., Nielsen O.B., Lamb G.D. and Stephenson D.G. (2004). Intracellular acidosis enhances the excitability of the working muscle. Science 305, 1144-1147.
81. Pellerin L., Pellegri G., Bittar P.G., Charnay Y., Bouras C., Martin, J.-L., Stella N. and Magistretti P.J. (1998). Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev. Neurosci. 20, 291-299.
82. Perkins G., Renken C., Martone M.E., Young S.J., Ellisman M. and Frey T. (1997). Electron tomography of neuronal mitochondria: three dimensional structure and organization of cristae and membrane contacts. J. Struct. Biol. 119, 260-272.
83. Philp N.J., Yoon H. and Lombardi L. (2001). Mouse MCT3 gene is expressed preferentially in retinal pigment and choroid plexus epithelia. Am. J. Physiol. Cell Physiol. 280, C1319-C1326.
84. Philp N.J., Ochrietor J.D., Rudoy C., Muramatsu T. and Linser P.J. (2003a). Loss of MCT1, MCT3, and MCT4 expression in the retinal epithelium and neural retina of the 5A11/basigin-null mouse. Invest. Ophthalmol. 44, 1305-1311.
85. Philp N.J., Wang D., Yoon H. and Hjelmeland L.M. (2003b). Polarized expression of monocarboxylate transporters in human retinal pigment epithelium and ARPE-19 cells. Invest. Ophthalmol. Vis. Sci. 44, 1716-1721.
86. Pierre K. and Pellerin L. (2005). Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J. Neurochem. 94, 1-14.
87. Pierre K., Parent A., Jayet P.Y., Halestrap A.P., Scherrer U. and Pellerin L. (2007). Enhanced expression of three monocarboxylate transporter isoforms in the brain of obese mice. J. Physiol. 583, 469-486.
88. Pitts K.R., Yoon Y., Krueger E.W. and McNiven M.A. (1999). The dynamin-like protein DLP1 is essential for normal distribution and morphology of the endoplasmic reticulum and mitochondria in mammalian cells. Mol. Biol. Cell 10, 4403-4417.
89. Ponsot E., Zoll J., N'Guessan B., Ribera F., Lampert E., Richard R., Veksler V., Ventura-Clapier R. and Mettauer B. (2005). Mitochondrial tissue specificity of substrates utilization in rat cardiac and skeletal muscles. J. Cell Physiol. 203, 479-486.
90. Poole R.C. and Halestrap A.P. (1993). Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am. J. Physiol. 264, C761-782.
91. +/lactate cotransporter (MCT1). Biochem. J. 320, 817-824.
92. Popinigis J., Antosiewicz J., Crimi M., Lenaz G. and Wakabayashi T. (1991). Human skeletal muscle: participation of different metabolic activities in oxidation of l-lactate. Acta Biochim. Pol. 38, 169-175.
93. Rahman B., Schneider H-P., Bröer A., Deitmer J.W. and Bröer S. (1999). Helix 8 and helix 10 are involved in substrate recognition in the rat monocarboxylate transporter MCT1. Biochemistry 38, 11577-11584.
94. Rasmussen H.N., van Hall G. and Rasmussen U.F. (2002). Lactate dehydrogenase is not a mitochondrial enzyme in human and mouse vastis lateralis muscle. J. Physiol. 541, 575-580.
95. Renken C., Siragusa G., Perkins G., Washington L., Nulton J., Salamon P. and Frey T.G. (2002). A thermodynamic model describing the nature of the crista junction: a structural motif in the mitochondrion. J. Struct. Biol. 138, 137-144.
96. Reyes J.G., Herrera E., Lobos L., Salas K., Lagos N., Jorquera R.A., Labarca P. and Benos D.J. (2002). Dynamics of intracellular calcium induced by lactate and glucose in rat pachytene spermatocytes and round spermatids. Reproduction 123, 701-710.
97. Ruskell G.L., (2005). The eye. In: Gray's anatomy: The anatomical basis of clinical practice. 39th ed. Standring S. (ed). Elsevier/Churchill Livingstone. Edinburgh. pp 701-720.
98. Saadi S., Wrenshall L.E. and Platt J.L. (2002). Regional manifestations and control of the immune system. FASEB J. 16, 849-856.
99. Sahlin K. and Katz.A. (1986). The content of NADH in rat skeletal muscle at rest and after cyanide poisoning. Biochem. J. 239, 245-353.
100. Sahlin K., Fernstrom M., Svensson M. and Tonkonogi M. (2002). No evidence of an intracellular lactate shuttle in rat skeletal muscle. J. Physiol. 541.2, 569-574.
101. Schorr H., Vaday G.G. and Lider O. (2000). Modulation of leukocyte behavior by an inflamed intracellular matrix. Dev. Immunol. 7, 227-238.
102. Shearman M.S. and Halestrap A.P. (1984). The concentration of the mitochondrial pyruvate carrier in rat liver and heart mitochondria determined with alpha-cyano-beta-(1-phenylindol-3-yl) acrylate. Biochem. J. 223, 673-676.
103. Sjogaard G. (1990). Exercise-induced muscle fatigue: the significance of potassium. Acta Physiol. Scand. 140, 1-63.
104. Smirnova E., Shurland D.L., Ryazantsev S.N. and Van der Bliek A.M. (1998). A human dynamin-related protein controls the distribution of mitochondria. J. Cell Biol. 143, 351-358.
105. Spriet L.L., Howlett R.A. and Heigenhauser G.J.F. (2000). An enzymatic approach to lactate production in human skeletal muscle during exercise. Med. Sci. Sports Exerc. 32, 756-763.
106. Stainsby W.N. and Brooks G. A. (1990). Control of lactic acid metabolism in contracting muscles and during exercise. Exerc. Sport Sci. Rev. 18, 29-63.
107. Takano T., Tian G.F., Peng W., Lou N., Libionka W., Han X. and Nedergaard M (2006). Astrocyte-mediated control of cerebral blood flow. Nat. Neurosci. 9, 260-267.
108. Ullah M.S., Davies A.J. and Halestrap A.P. (2006). The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1-dependent mechanism. J. Biol. Chem. 281, 9030-9037. Valenti D., de Bari L., Atlante A. and Passarella S. (2002). L-Lactate transport into rat heart mitochondria and reconstitution of the llactate/ pyruvate shuttle. Biochem. J. 364, 101-104.
109. Walker J.E. (1992). The mitochondrial transporter family. Cur. Op. Struct. Biol. 2, 519-526.
110. 2 and the role of lactate production in oxyhemoglobin dissociation during exercise. In: Oxygen transport to tissue XXI. Eke and Delpy (eds). Plenum Publishers. New York. pp 321-333.
111. max of mitochondrial electron shuttles in rat skeletal muscle and liver. Med. Sci. Sports Exerc. Suppl. 35, S396.
112. Wilson E.J. (1987). Should nagarse be used during the isolation of brain mitochondria? Neurochem. Res. 12, 831-834.
113. Wilson M.C., Jackson V.N., Heddle C., Price N.T., Pilegaard H., Juel C., Bonen A., Montgomery I., Hutter O.F. and Halestrap A.P. (1998). Lactic acid efflux from white skeletal muscle is catalyzed by the monocarboxylate transporter isoform MCT3. J. Biol. Chem. 273, 15920-15926.
114. Wilson M.C., Meredith D. and Halestrap A.P. (2002). Fluorescence resonance energy transfer studies on the interaction between the lactate transporter MCT1 and CD147 provide information on the topology and stoichiometry of the complex in situ. J. Biol. Chem. 277, 3666-3672.
115. Wilson M.C., Meredith D., Manning Fox J.E., Manoharan C., Davies A.J. and Halestrap A.P. (2005). Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is embigin (gp70). J. Biol. Chem. 280, 27213-27221.
116. Yoon H. and Philp N.J. (1998). Genomic structure and developmental expression of the chicken monocarboxylate transporter MCT3 gene. Exp. Eye Res. 67, 417-424.
117. Yoon N.Y., Fanelli A., Grollman E.F. and Philp N.J. (1997). Identification of a unique monocarboxylate transporter (MCT3) in retinal pigment epithelium. Biochem. Biophys. Res. Commun. 234, 90-94.
118. Yoshida Y., Holloway G.P., Ljubicic V., Hatta H., Spriet, L.L., Hood D.A. and Bonen A. (2007). Negligible direct lactate oxidation in subsarcolemmal and intermyofibrillar mitochondria obtained from red and white skeletal muscle. J. Physiol. 582, 1317-1335.